FIGS (NYSE:FIGS) FY Conference Transcript

Summary of FIGS (NYSE:FIGS) FY Conference Call - March 04, 2026 Company Overview - FIGS is a digitally native company specializing in medical scrubs, selling products globally through its website and an emerging retail footprint [14][13] - The company aims to create premium, functional, and comfortable products for healthcare professionals, disrupting a long-standing industry [14][13] Industry Insights - The medical apparel industry is large, mandated, and replenishment-driven, with 140 million healthcare professionals globally [14] - FIGS has 2.9 million active customers, indicating significant growth potential in a market that lacks strong branding [14] Financial Performance - Q4 2025 revenue growth was reported at 33%, attributed to product innovation, effective marketing, and industry normalization [17][21] - Active customer base grew by 9%, with improvements in average order value and orders per customer contributing to revenue growth [44] Product Innovation - FIGS is known for its proprietary FIONx fabric, which is durable and comfortable, and has recently launched FORMx for more intense environments [23][24] - The company has expanded its product line beyond scrubs to include medical-grade compression socks and other accessories, driving broad-based growth [26][27] Marketing Strategy - FIGS has focused on top-of-funnel storytelling and viral marketing campaigns, significantly increasing brand engagement and customer acquisition [18][20] - The company outfitted Team USA's medical team for the 2024 Olympics, enhancing brand visibility [19] Global Expansion - FIGS operates in 59 countries, with a focus on Canada, Mexico, the U.K., and Australia for deeper market penetration [29][30] - International sales grew by 55% in the quarter, with plans to enter 20 additional markets in 2026 [32] Retail Presence - FIGS has transitioned to an omni-channel model with five Community Hubs and plans to open four more, enhancing customer experience and engagement [34][38] - Over 40% of customers in stores are new to the brand, indicating successful customer acquisition strategies [38] B2B Opportunities - The "teams business" is a growing segment, currently less than 10% of total sales, with potential for significant growth as healthcare institutions seek to standardize and brand their teams [39][42] - The concierge medicine market is projected to grow from $15 billion to $30 billion over the next decade, positioning FIGS favorably [43] Financial Outlook - The company anticipates a modest increase in gross margins despite tariff pressures, with a guidance for adjusted EBITDA margin expansion to 12.7%-12.9% in 2026 [52] - FIGS has a strong balance sheet with $300 million in cash and no debt, allowing for continued investment in growth and a share buyback program [54][55] Key Risks and Considerations - Tariff impacts are expected to pressure margins by 400 basis points, but FIGS has strategies in place to mitigate these effects [45][48] - The company is focused on leveraging operational efficiencies and marketing investments to sustain growth and profitability [50][51]